Overview
Also known as:
FDA & Trial Timeline
5 eventsRutgers, The State University of New Jersey — NA
Centre Hospitalier Universitaire de Saint Etienne — NA
Chang Gung Memorial Hospital
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León — NA
Steba Biotech S.A. — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Borderline vascular tumor.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Borderline vascular tumor at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Borderline vascular tumor.
Community
No community posts yet. Be the first to share your experience with Borderline vascular tumor.
Start the conversation →Latest news about Borderline vascular tumor
Disease timeline:
New recruiting trial: Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
A new clinical trial is recruiting patients for Borderline vascular tumor
New recruiting trial: Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
A new clinical trial is recruiting patients for Borderline vascular tumor
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Borderline vascular tumor
Which specialists treat Borderline vascular tumor?
4 specialists and care centers treating Borderline vascular tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.